Jim Cramer Recommends Boeing, Celgene, This Stock; Shuns Boston Private
Jim Cramer made the following calls on July 19th, 2013. What do you think about his picks?
Boeing Co. (NYSE:BA): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on July 11, 2013. The stock’s 52-week high is $108.15, and its 52-week low is $69.03.
Cramer again told viewers to get in Boeing last night, a company he feels is a great buy for the long haul. Despite repeated problems with the Dreamliner 787 this year, the company continues to show resilience, as its share price sits at over $106, within striking distance of its 52-week high. Reporting for the second quarter is due out on this Wednesday, and the company continues to roll out orders of its Dreamliner plane. Hainan Airlines received their first of 10 Boeing Dreamliners earlier this month.
Boston Private Financial Holdings Inc. (NASDAQ:BPFH): Jim Cramer ranked this stock a Sell. The stock’s 52-week high is $11.49, and its 52-week low is $8.35.
Simply put, Cramer said it was not his favorite bank, and encouraged viewers to buy Wells Fargo (NYSE:WFC) instead, a stock he has been advocating for a while and which his charitable trust owns. Boston Private’s second quarter results came out last week, and saw an uptick in the company’s cash by way of a sale of private banks it held in the U.S. According to Clayton G. Deutsch, Chief Executive Officer and President, “In the second quarter, we completed two significant transactions: the sale of our Pacific Northwest private banking offices and the repurchase of our preferred shares held by The Carlyle Group. While these transactions complicated our second quarter results, they strengthened the Company. With these transactions completed, we are fixated on core business growth and performance.”
Amphenol Corporation (NYSE:APH): Jim Cramer ranked this stock a Buy. The stock’s 52-week high is $85.66, and its 52-week low is $55.99.
Cramer told viewers to purchase Amphenol when it was mentioned during the lightning round, saying that, “That is strong. I like that business. It is an opportunity.” The company released second quarter financials last week, and noted an increase in earnings, up to $0.95 from $0.86 from the same period last year. Amphenol also increased its dividend to $0.20 per share, and got a buy rating from Cramer’s website, which said that, “The company’s strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, good cash flow from operations and largely solid financial position with reasonable debt levels by most measures.”
Celgene Corporation (NASDAQ:CELG): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on July 1, 2013. The stock’s 52-week high is $137.80, and its 52-week low is $63.89.
With results for the quarter scheduled for Thursday, Cramer said he is a fan of the stock, and recommended it to viewers. The stock is up over 1 percent today to begin the week, trading at $137.43, approaching its 52-week high. Celgene finished phase III testing of a drug intended to treat multiple myeloma, and had success with patients, meeting a goal of ‘progression-free survival’. Negotiations with regulators are underway to begin the marketing of the drug.